Skip to content

Treatment for Poly Cystic Ovarian Syndrome

Pharmaceutico - Clinical Validation of Kalyanaka Kshara in the Management of P.C.O.S Induced Infertility

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018084
Enrollment
120
Registered
2019-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Kalyanaka Kshara: 50 patients will be administered with Kalyanaka Kshara 250mg orally twice daily for 90 days Control Intervention1: Rajah Pravartini Vati: A group of 50 patients will b

Sponsors

Dr S Anitha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married infertility patients with P.C.O.D. (Rotterdam criteria) Irregular menses scanty menses due to Anovulatory cycle Anovulation and Oligo amennorohoea Elevated LH (LH:FSH ratio >3) Clinical or biochemical evidence of Hyperandrogenism Polycystic ovary (more than 10 follicles in a ovary or one cyst more than 10 mm) Willing to give pre-informed consent for the study

Exclusion criteria

Exclusion criteria: Unmarried patients with P.C.O.D. Age below 20 years and above 40 years Patients associated with other gynaecological disorders Patients suffering with any chronic diseases Women having the history of primary amenorrhea Patients with Tubercular endometritis Patients with congenital anomalies in female genital tract Patients with chronic liver disease, renal disorder, etc. Patients with metabolic and other Endocrinal disorders like Diabetes Mellitus Patients with Hypothyroidism

Design outcomes

Primary

MeasureTime frame
Relief in signs and symptoms and significant improvement of objective parameters tests to 50% baselineTimepoint: Every month 30th day, 60th day, 90th day

Secondary

MeasureTime frame
Improvement in objective parameters Achievement of Ovulation and FertilityTimepoint: 30th day, 60th day, 90th day

Countries

India

Contacts

Public ContactDR ANITHA SUDDALA

Dr NTR University of Health Sciences

prasadpvnr@gmail.com9666671664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026